Publication on the implementation of the National Strategy for Genomic Medicine in Germany now available
© genomDE
How has the National Strategy for Genomic Medicine been implemented previously in order to integrate genome sequencing into healthcare in a structured and quality-assured manner and how is this currently being done?
Those involved answer this question jointly in the publication entitled “The national genomDE strategy: Paving the way for genomics-based personalised healthcare and translational research in Germany” which has recently been published in the online edition of Nature Medicine. This paper offers the first comprehensive insight into the preparation and implementation of the genomDE strategy and the status of the genomDE model project (based on Section 64e of the German federal Social Code, Book V) – from the technical, data protection, and organisational fundamentals to the crucial roles of contributing protagonists.
Key contents of the publication:
- Interdisciplinary collaboration within the framework of genomDE
- Expansion of the national data infrastructure
- Requirements for data collection, quality assurance, and processing
- Current status and outlook of the model project
The National Strategy for Genomic Medicine has paved the way for more precise diagnoses and individualised treatment recommendations for patients with rare and advanced oncological diseases. Germany’s genomic healthcare and research are now set to gather pace.
Further Information
